| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhat is the selected pain-related question?Required |
The selection is reduced severe-pain days, acute analgesic use, or attack duration. Outcomes are distinguished within the existing subclaim without creating new trials or separate independent questions. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Original question covering severe-pain days, acute analgesic use and attack duration |
Material needed: Original wording and change records linking the selection with its parent prevention context are needed. Explaining outcomes separately does not make them new independent trials. This records needed materials; no new research was executed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionHow do selected D and parent D30 differ?Required |
The original explanation for selected D is that within-group changes occurred without a between-group advantage. Parent D30 concerns attack prevention and responder outcomes and is not transferred as the selected question's score. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between question-specific grades, scores, status and original explanations |
Material needed: Separate score, status and axes are absent from the selection. Original selected and parent records must be preserved, with their scopes distinguished if an authorized correction occurs. This records needed materials; no new research was executed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWhich ginger dry extract do these findings concern?Required |
The account concerns ginger dry extract standardized to 5% active constituents. It is distinguished from culinary ginger and combination products without converting this into a specific gingerol content or equivalence across all ginger products. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Single-ingredient oral extract, active-constituent standardization and product conditions |
Material needed: Original constituent markers, quantities, manufacturing, excipients, raw materials and quality records are needed. Direct effects are not transferred merely because products share a name. This records needed materials; no new research was executed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat does 200 mg, 3 times daily for 3 months describe?Required |
The preserved condition is dry extract 200 mg, 3 times daily for 3 months. It is not converted into new dosing instructions or an optimal dose, and total daily or active amounts are not calculated. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Original trial exposure schedule, adherence, discontinuation and measurement timing |
Material needed: Original records linking actual administration, adherence, discontinuation and changes to visit-specific outcome denominators are needed. Scheduled and actual exposure are not treated as identical. This records needed materials; no new research was executed. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionWhich adults with episodic migraine were studied?Required |
The account concerns a placebo-controlled trial of 107 adults with episodic migraine. Overall size alone does not verify arm-specific characteristics or analysis denominators for the selected outcomes. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Diagnosis, baseline severity, eligibility and concurrent care |
Material needed: Original eligibility, diagnosis, baseline attacks and pain, preventive and acute medication, exclusions and arm-specific distributions are needed. Applicability is not extended to other patient groups. This records needed materials; no new research was executed. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionWhat placebo provided the direct comparison?Required |
The original design is a double-blind placebo-controlled randomized trial. Interpretation distinguishes direct comparison with placebo from changes in the ginger arm alone. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Placebo composition, blinding, background care and direct between-arm comparisons |
Material needed: Placebo ingredients, appearance and sensory matching, arm-specific concurrent care, adherence and contrast plans are needed. Design labels alone do not verify procedural details. This records needed materials; no new research was executed. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionAre 3-month prevention and acute-attack treatment the same question?Required |
The original trial concerns 3-month prevention. Acute analgesic use and attack duration are outcomes within that prevention trial and are not converted into a claim that ginger immediately treats pain. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between outcomes within prevention, acute treatment and post-treatment persistence |
Material needed: Baseline observation, visits, attack definitions, diaries and outcome-specific measurement windows are needed. Post-treatment persistence and contributions from acute treatment require separate information. This records needed materials; no new research was executed. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionHow were the three outcomes measured and expressed?Required |
The selection and preserved endpoint list distinguish severe-pain days, analgesic use and duration. Different measurements are not combined into one effect estimate or a shared denominator. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Definitions and aggregation of severe-pain days, acute medication use and attack duration |
Material needed: The severe-pain threshold, aggregation of days, attacks and medication use, time units, recorders, timing and individual denominators are needed. Outcome names in the summary do not establish measurement details. This records needed materials; no new research was executed. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionWhat is the original finding for severe-pain days?Required |
The preserved account reports no significant between-arm difference in severe-pain days. This is not converted into absence of painful days or proof of an exact zero effect or equivalence. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Direct between-arm estimate, interval, units and denominator for severe-pain days |
Material needed: Original result tables specifying pain-day definitions, aggregation, denominators, adjustment and exact effects, CIs and P values are needed. Missing values are not filled using another outcome's numbers. This records needed materials; no new research was executed. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionWhat is the original finding for acute analgesic use?Required |
The account also reports no between-arm difference in acute analgesic use. This is not converted into medication discontinuation, replacement or direct acute analgesic efficacy of ginger. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Acute medication types, use aggregation and direct comparison with placebo |
Material needed: Medication types, rescue rules, quantities and frequency, background-medication changes, denominators, exact effects and intervals are needed. No new tapering or treatment guidance is created. This records needed materials; no new research was executed. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionWhat is the original finding for attack duration?Required |
The preserved account also reports no between-arm difference in attack duration. This is not extended to identical responses in all attacks or individuals, or a definitive absence of immediate effects. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Attack onset, ending, time aggregation and between-arm estimation |
Material needed: Original attack diaries, onset and ending definitions, time units, duplicate aggregation, acute-medication effects, models, denominators and CIs are needed. Exact durations or effects are not newly calculated. This records needed materials; no new research was executed. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionIs the 50% responder outcome the same as the selected pain outcomes?Required |
The proportion with at least a 50% reduction in attacks belongs to the parent prevention context and another subclaim. It is not transferred as the same measure or denominator for pain days, analgesic use or duration. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between the parent responder outcome and pain days, medication use and duration |
Material needed: Prespecified plans, hierarchy, full result tables, denominators and analyses for each outcome are needed. The responder criterion is not used as a clinical threshold for other outcomes. This records needed materials; no new research was executed. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionHow should changes over time in both arms be interpreted?Required |
The original selected explanation states that within-arm changes occurred without a between-arm advantage. Improvement in both arms is not converted into an added ginger benefit over placebo. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between within-arm changes and direct effects versus placebo |
Material needed: Baseline, final and time-specific values, direct between-arm contrasts, adjustment models, intervals and denominators are needed. Within-arm changes are not subtracted to create a new effect. This records needed materials; no new research was executed. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionDoes no between-arm difference prove an exact zero effect?Required |
The original counterview explains that exact intervals are insufficient to assign F and completely exclude a small benefit. Between-arm nonsignificance is not converted into an exact zero effect or equivalence. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between effect magnitude, exact intervals, precision and importance |
Material needed: Exact point estimates, CIs, variance, denominators, models and clinical importance thresholds for each outcome are needed. No new CIs, effects, grades or equivalence judgments are created. This records needed materials; no new research was executed. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionWhat denominator does the figure of 107 adults describe?Required |
The original 107 adults describe the overall randomization context. This is not directly used as each arm's or pain outcome's valid analysis count, attack or diary count, or harms denominator. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Overall randomized size versus arm, outcome, attack and diary analysis denominators |
Material needed: Flow diagrams, arm-specific allocation, completion, exclusions, outcome denominators, diary and attack units and observation time are needed. New participant or event totals are not calculated. This records needed materials; no new research was executed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionDo randomized and double-blind labels verify the procedures?Required |
The original randomized and double-blind design labels are retained. Design strengths described in parent materials are not converted into a new formal bias assessment or completed content review. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Details of allocation, concealment, blinding and outcome measurement |
Material needed: Sequence generation, concealment, blinded parties and maintenance, assessors, baseline balance and measurement procedures are needed. External originals are not labeled as read. This records needed materials; no new research was executed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionAre the selected outcomes' prespecified hierarchy and analyses verified?Required |
The original endpoint list includes responder and pain-related outcomes together. Lists or labels in parent materials do not establish the prespecified hierarchy of primary, secondary or co-primary outcomes. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Outcome hierarchy and changes in registration, protocols and analysis plans |
Material needed: Original registration history, protocols, analysis plans, plan timing, changes and multiplicity handling are needed. Current materials are not used as certification of preregistration. This records needed materials; no new research was executed. |
| 18 |
Unverified |
Full text not readStored summary read |
N18 · Evidence conditionWho measured the outcomes, using which diaries and instruments?Required |
The stored summary names the pain-related outcomes but does not provide recording-instrument or aggregation details. This is not treated as proof of nonreporting in the entire paper or measurement failure. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Recording, validation and measurement windows for pain, medication use and duration |
Material needed: Original diaries, scales, recorders, assessor blinding, record validation, missing entries and time-window records are needed. Measurement procedures unverified within the preserved scope remain unverified. This records needed materials; no new research was executed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionAre adherence, deviations and background medication distinguished from ginger's contribution?Required |
Prevention-trial assignment is distinguished from the acute-medication-use outcome. The stored summary alone does not establish actual arm-specific adherence, background medication, additional care or their effects. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Actual exposure, preventive and acute medications, changes and analysis targets |
Material needed: Administration, concurrent care, changes, discontinuation, crossover, arm-specific records and analysis plans are needed. Changes in concurrent care are not attributed solely to ginger itself. This records needed materials; no new research was executed. |
| 20 |
Unverified |
Full text not readStored summary read |
N20 · Evidence conditionWhich outcomes and records were missing from analysis?Required |
Overall randomized size is not used as every outcome's valid denominator. Missingness and handling for individual pain outcomes, attacks and diaries are unverified in the stored summary. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Missing data and follow-up loss by arm, outcome, attack and diary |
Material needed: Dropout, exclusions, record-validity criteria, arm-specific missingness, adjustments and sensitivity analyses are needed. Absence of missing data or analysis of every participant is not assumed. This records needed materials; no new research was executed. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionWhich effect was estimated for each outcome?Required |
The original account of no core between-arm differences is preserved. Analysis populations, target effects and models for pain days, analgesic use and duration are not newly estimated. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Analysis populations, units, direct contrasts, adjustment and repeated measurements |
Material needed: ITT and PP distinctions, baseline adjustment, repeated-attack and measurement models, exact estimates, CIs and denominators are needed. Different analysis levels are not combined as the same result. This records needed materials; no new research was executed. |
| 22 |
Unverified |
Full text not readStored summary read |
N22 · Evidence conditionIs the clinical importance of the pain outcomes established?Required |
The account describes insufficient exact CIs and external clinical importance thresholds. Overall nonsignificance alone does not establish an individual's benefit or absence of an important effect. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Units, importance thresholds and patient-important changes for each measure |
Material needed: Measurement evidence, thresholds, distributions, intervals and patient-importance information for each outcome are needed. Arbitrary importance boundaries or individual applications are not created. This records needed materials; no new research was executed. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionCan 3-month findings be applied to longer periods, other populations or doses?Required |
The original scope is 3-month single-ingredient prevention in episodic migraine. Culinary ginger, other formulations and periods, acute treatment or post hoc subgroups are not automatically included. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Scope of trial duration, population, dose and post-treatment persistence |
Material needed: Post-treatment follow-up, direct comparisons, original exposure and prespecified subgroup and interaction information are needed. Persistence or effects in other populations are not newly established. This records needed materials; no new research was executed. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionAre no between-arm differences and within-arm changes both preserved?Required |
The original lack of core between-arm differences and the selected explanation's within-arm changes are retained together. Improvement in both arms is not converted into an added ginger benefit, and unfavorable findings are not removed. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Complete results, within-arm changes, direct comparisons and precision gaps |
Material needed: Complete original result tables, outcome and report lists, exact estimates and intervals are needed. No new conflict judgment is created without establishing the scope of conflicting or additional reports. This records needed materials; no new research was executed. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionAre shared reports and outcomes counted as independent trials?Required |
The preserved evidence and bibliography concern the same Martins 2020 prevention report. The original sole-direct-prevention-trial statement is retained, while reused outcomes and parent materials are not added as independent replication. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Links between the same report, trial, cohort and selected or parent outcomes |
Material needed: Original registration, recruitment, related reports and family links between outcomes and analyses are needed. Unique trial, participant, attack and event totals remain unverified. This records needed materials; no new research was executed. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionDo acute combination and active-control studies replicate the same prevention question?Required |
The account did not count acute feverfew–ginger combinations or sumatriptan active controls as replication of 3-month single-ingredient ginger prevention. Nausea or other symptom findings are not transferred as the same outcomes either. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between feverfew combinations, sumatriptan controls and single-ingredient prevention |
Material needed: Authorized existing originals and information on intervention, population, comparator, period and outcome relevance are needed. Bibliographies, effects or independent-replication counts absent from the original account are not created. This records needed materials; no new research was executed. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionWhat does the identifier NCT02570633 establish?Required |
NCT02570633 is preserved in the original evidence and bibliography. Presence of the string is not converted into current reading of registration originals, identity verification or confirmation of prespecified analysis. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between the registration string, registration content and prespecification |
Material needed: Original registration history, protocols, analysis plans and links to reports are needed. Registration URLs are not guessed and unread content is not labeled as verified. This records needed materials; no new research was executed. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Evidence conditionWhat do manufacturer independence and full-text support checking describe?Required |
The parent account describes manufacturer independence and checking support details in the original text, retaining full-text checking language in English. These are historical records, not current full-text reading or new certification of independence. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between historical support-checking statements and current reading or role verification |
Material needed: Original funding, COI and roles in finance, product provision, authorship, analysis and publication are needed. Historical checking statements are not inherited as completed current external comparison. This records needed materials; no new research was executed. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionWhich materials were actually read and which are needed?Required |
The linked content was transferred from the stored parent summary and selected question. External abstracts, full texts, registration, plans, diaries and support materials are unread, with access not attempted. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between stored summaries, external abstracts, full texts, registration and needed materials |
Material needed: Authorized originals, individual result tables, diaries, registration and plans are needed. Links or needed-material entries are not converted into acquisition, full-text reading or access failure. This records needed materials; no new research was executed. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Evidence conditionHow do the original evidence date and this production date differ?Required |
The original evidence date is 2026-09-07 and the correction list is empty. Historical cross-checking or verification language is not converted into a current external-reading or completed-content-review date. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Preserved evidence date, historical checking, corrections and production timing |
Material needed: Actual historical access locations, timing, search scope and original correction records are needed. Evidence dates, condition-authoring dates and view-production dates are preserved as separate roles. This records needed materials; no new research was executed. |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Evidence conditionAre the selected Korean and English wording and parent context retained?Required |
The selected Korean and English wording lists severe-pain days, acute analgesic use and attack duration, preserving within-arm changes without between-arm advantage. Parent prevention and responder conditions are not automatically applied to the selected outcomes. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Original wording, grade and explanation for pain outcomes versus parent prevention context |
Material needed: The original selected and parent wording in both languages must be linked to authorized correction records. Scores or status absent from the selection are not created during translation. This records needed materials; no new research was executed. |
| 32 |
Partly verified |
Full text not readStored summary read |
N32 · Evidence conditionDo parent axes and empty fields certify review of the selected outcomes?Required |
Parent B/P/R1/I2/E0/B1/C0, false flags and empty correction or deliberation fields are preserved in the original. These are not converted into new selected-outcome scores, axes, formal assessments or completed content review. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Parent axes and flags versus absence of a separate selected-question assessment |
Material needed: The applicable question for each original field and authorized change records must be distinguished. Numbers or empty fields are not used as new certification of independence, precision or safety. This records needed materials; no new research was executed. |
| 33 |
Partly verified |
Full text not readStored summary read |
N33 · Evidence conditionWhat harm information concerns heartburn and abdominal discomfort?Required |
The original safety account mentions possible heartburn and abdominal discomfort with ginger supplements. This is not treated as an available trial-specific event table, and general cautions are not converted into new incidence estimates. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
General cautions versus direct event data for the selected product |
Material needed: Original adverse-event definitions, collection, severity, arm-specific people and events, exposure and denominators are needed. Reporting gaps are not labeled as absence of events or safety. This records needed materials; no new research was executed. |
| 34 |
Unverified |
Full text not readStored summary read |
N34 · Evidence conditionAre harm onset, discontinuation and recovery times known?Required |
The 3-month prevention-effect observation period is not converted into an exact timeline of harm onset or recovery. Arm-specific harms follow-up and timing relationships are unverified in the stored summary. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Timing of exposure, event onset, recovery and re-exposure |
Material needed: Original records of exposure, onset, latency, discontinuation, recovery, re-exposure and observation periods are needed. Missing timing information does not establish absence of harm. This records needed materials; no new research was executed. |
| 35 |
Unverified |
Full text not readStored summary read |
N35 · Evidence conditionCan harm frequency and comparative risk be established?Required |
The overall 107 adults and lack of core between-arm differences do not establish a harms analysis denominator or absence of events. General cautions are not calculated into incidence or comparative risks. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Denominators for exposed people, events, time and direct comparisons |
Material needed: Arm-specific events, people, duplication, exposure, observation time, collection methods, direct comparisons and CIs are needed. Risk numbers are not created from material without denominators. This records needed materials; no new research was executed. |
| 36 |
Partly verified |
Full text not readStored summary read |
N36 · Evidence conditionWhat is the scope of anticoagulant, antiplatelet, bleeding and surgery cautions?Required |
Original cautions concerning anticoagulants, antiplatelets, bleeding risk and surgery are retained. They are not converted into new interaction magnitudes, causal conclusions or treatment guidance for the selected population. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Existing concurrent-medication and baseline-risk cautions versus direct interaction data |
Material needed: Concurrent medication, baseline risk, alternative causes, direct events and long-term, rare-harm and special-population information are needed. New medication changes or discontinuation instructions are not proposed. This records needed materials; no new research was executed. |
| 37 |
Unverified |
Full text not readStored summary read |
N37 · Evidence conditionCan missing reports and repeated citations be counted as independent harm events?Required |
Sharing across parent and subclaims or Korean and English accounts does not create new independent events. The stored summary lacks a list establishing unique original events and report families. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Harms collection, follow-up loss, unique people and events, and report families |
Material needed: Original collection, detection, reporting, follow-up loss and family links between related reports are needed. Repeated citations are not added as events, and missing reporting is not converted into absence of events. This records needed materials; no new research was executed. |
| 38 |
Partly verified |
Full text not readStored summary read |
N38 · Evidence conditionHow far do the original null findings and evidence gaps extend?Required |
The explanation for selected D and the parent's direct prevention findings are preserved. They are not extended into verification of exact zero effects, an F grade, acute-treatment efficacy or overall safety. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Between-arm nonsignificance, within-arm changes, precision and interpretation for each outcome |
Material needed: Individual effects, CIs, clinical importance thresholds, denominators, prespecified plans, long-term and harms information are needed. Limits of findings, precision and individual applicability must be distinguished. This records needed materials; no new research was executed. |
| 39 |
Partly verified |
Full text not readStored summary read |
N39 · Evidence conditionDo preserved methodological and condition links establish completed content review?Required |
Preserved methodology, condition templates and contracts are records linked for production. Their connection is not labeled as external-original reading, a new formal assessment or completed clinical content review. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Distinction between methodological records, condition production and clinical content review |
Material needed: The source, scope and incomplete-review state of each condition must be retained. Technical view and file checks do not substitute for clinical content approval or a new judgment. This records needed materials; no new research was executed. |
| 40 |
Partly verified |
Full text not readStored summary read |
N40 · Evidence conditionWhich incoming materials would update the gaps?Required |
This production transfers original D, lack of between-arm differences, within-arm changes and precision gaps. Recording needed materials is not converted into new research or completed content review. |
This information was transferred from the stored summary with the selected question distinguished from parent materials. Detailed originals and review of existing content remain incomplete; it does not establish clinical certification or review approval. |
Outcome-specific definitions, denominators, effects, plans, families and change records |
Material needed: When authorized original results, diaries, plans, family information or corrections arrive, the complete prior version must be preserved. Evidence additions, condition changes and judgment changes are distinguished while retaining each outcome's boundaries. This records needed materials; no new research was executed. |